YKYuka Kanno

Yuka Kanno

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yuka Kanno has a total of 428 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Interferons and STAT1 dynamically modulate integrated stress response outcomes in CD8 T cells

    by Rachael Philips, Kang Yu, Yi-Chu Liao, SeolKyoung Jung, Kan Jiang, Yuka Kanno, Davide Randazzo, Scott Oakes, John O'SHea

    Type I interferons (IFN-I) drive both protective and pathological CD8 T cell responses. Patients with activating STAT1 mutations exhibit enhanced IFN responses with T cell dysfunction and autoimmunity; however, mechanisms underlying excess versus impaired response remain unclear. We used mouse models expressing a STAT1 mutation ( Stat1 -T385M) ubiquitously or T-cell selectively to dissect T cell-intrinsic versus cell-extrinsic actions of activating STAT1. Global Stat1 -T385M expression had increased lethality upon acute viral infection with CD8 T cell dysfunction marked by stress response activation rather than classical exhaustion. This dysfunction was extrinsic, as T-cell-restricted Stat1 -T385M preserved expansion, cytokine production, and checkpoint receptor expression. However, intrinsic Stat1 -T385M reshaped differentiation by suppressing T-bet and effector programs while upregulating a stress signature seen in memory lymphocytes. The extrinsic-intrinsic switch depended on IFN-I magnitude, with exaggerated levels triggering a pro-apoptotic stress response. Therefore, STAT1 works as a rheostat balancing CD8 differentiation and stress, as a basis for interferonopathies.

  • Open Access

    Paxbp1 restrains cytotoxic and innate cell programs in CD4+ T cells to promote Th2 differentiation

    by Danielle Chisolm, Yuki Morimoto, Hiroyuki Nagashima, Stephen Brooks, Ijeoma Meremikwu, Micala Hammond, Jian Sun, Ebru Ermis, Rachael Philips, Vijender Chaitankar, et al.

    CD4+ T helper cell differentiation is important for efficient host defense and has largely been defined by the activities of a limited number of lineage-specifying transcription factors. However, these factors alone cannot explain the intricate series of events that concurrently induce a specialization program while repressing competing gene programs. In this study, we define a new role for Paxbp1 as an important regulatory factor in T helper cell specification events. We show that Paxbp1 expression is selectively induced in Th2 cells and is required for repression of innate and cytotoxic gene programming potential during Th2 differentiation. Paxbp1-deficiency enhances chromatin accessibility at genomic regions associated with innate lymphocyte programs in both in vitro and in vivo models of Th2 differentiation, indicating that Paxbp1 restrains activities that promote alternative cytotoxic programming potential. Mechanistically, we found Paxbp1 interacts with Bcl11b and Runx1, transcription factors established as negative and positive regulators of innate cytotoxic programming potential, respectively. Our data show that Paxbp1 ensures proper regulation of Bcl11b and Runx1-associated gene programs, and it provides new molecular insights into the complexity of the transcriptional regulatory network involved in CD4+ T cell specialization events.

  • An activating Stat1 mutant disrupts normal STAT4 innate lymphocyte programs during viral infection

    by Rachael L. Philips, Yi-Chu Liao, Colleen M. Lau, Tasha A. Morrison, Kan Jiang, Amal Hutchinson, Justin Shayne, Chen Yao, Joseph C. Sun, Heather D. Hickman, et al.

    Interferonopathies drive autoimmunity but can also impair host responses to pathogens, including viral infections. To better understand viral susceptibility of patients with STAT1 gain-of-function (GOF) mutations, we generated conditional knockin mouse models to elucidate disease mechanisms and relevance of different immune subsets. Virally infected Stat1 GOF mice exhibited impaired early IFN-γ production from innate lymphocytes and lethality because of excess prolonged multicytokine production. The presence of the Stat1 GOF allele resulted in premature usage of interferon-stimulated gene factor 3 (ISGF3) over the normal STAT4–AP-1–dependent transcriptomic program in activated innate lymphocytes. Administration of anti–IFN-γ antibodies in wild-type (WT) mice after infection phenocopied Stat1 GOF mice presenting exaggerated inflammation despite viral control. Conversely, early administration of exogenous IFN-γ to infected Stat1 GOF mice prevented lethality and exaggerated cytokine response. Although Stat1 GOF mutations facilitate IFN-γ–mediated autoimmunity, early IFN-γ responses to viral infection via a normal STAT4 program were impaired, leading to overcompensated inflammatory responses in Stat1 GOF mice.


  • Remodeling of Il4-Il13-Il5 locus underlies selective gene expression

    by Hiroyuki Nagashima, Justin Shayne, Kan Jiang, Franziska Petermann, Aleksandra Pękowska, Yuka Kanno, John J. O’sHea

    The type 2 cytokines, interleukin (IL)-4, IL-13 and IL-5 reside within a multigene cluster. Both innate (ILC2) and adaptive T helper 2 (TH2) lymphocytes secrete type 2 cytokines with diverse production spectra. Using transcription factor footprint and chromatin accessibility, we systemically cataloged regulatory elements (REs) denoted as SHS-I/II, KHS-I/II, +6.5kbIl13, 5HS-I(a, b, c, d, e), 5HS-II and 5HS-III(a, b, c) across the extended Il4-Il13-Il5 locus in mice. Physical proximities among REs were coordinately remodeled in three-dimensional space after cell activation, leading to divergent compartmentalization of Il4, Il13 and Il5 with varied combinations of REs. Deletions of REs revealed no single RE solely accounted for selective regulation of a given cytokine in vivo. Instead, individual RE differentially contribute to proper genomic positioning of REs and target genes. RE deletions resulted in context-dependent dysregulation of cytokine expression and immune response in tissue. Thus, signal-dependent remodeling of three-dimensional configuration underlies divergent cytokine outputs from the type 2 loci.


  • TGFβ prevents IgE-mediated allergic disease by restraining T follicular helper 2 differentiation

    by Tamara T. Haque, Katherine A. Weissler, Zoe Schmiechen, Karen Laky, Daniella M. Schwartz, Jenny Li, Michela Locci, Mathilde Turfkruyer, Chen Yao, Paul Schaughency, et al.

    Allergic diseases are common, affecting more than 20% of the population. Genetic variants in the TGFβ pathway are strongly associated with atopy. To interrogate the mechanisms underlying this association, we examined patients and mice with Loeys-Dietz syndrome (LDS) who harbor missense mutations in the kinase domain of TGFΒR1/2 . We demonstrate that LDS mutations lead to reduced TGFβ signaling and elevated total and allergen-specific IgE, despite the presence of wild-type T regulatory cells in a chimera model. Germinal center activity was enhanced in LDS and characterized by a selective increase in type 2 follicular helper T cells (T FH 2). Expression of Pik3cg was increased in LDS T FH cells and associated with reduced levels of the transcriptional repressor SnoN. PI3Kγ/mTOR signaling in LDS naïve CD4 + T cells was elevated after T cell receptor cross-linking, and pharmacologic inhibition of PI3Kγ or mTOR prevented exaggerated T FH 2 and antigen-specific IgE responses after oral antigen exposure in an adoptive transfer model. Naïve CD4 + T cells from nonsyndromic allergic individuals also displayed decreased TGFβ signaling, suggesting that our mechanistic discoveries may be broadly relevant to allergic patients in general. Thus, TGFβ plays a conserved, T cell–intrinsic, and nonredundant role in restraining T FH 2 development via the PI3Kγ/mTOR pathway and thereby protects against allergic disease.


  • Microbial ligand-independent regulation of lymphopoiesis by NOD1

    by Chiaki Iwamura, Hidetaka Ohnuki, Francis A. Flomerfelt, Lixin Zheng, Alexie Carletti, Hidefumi Wakashin, Yohei Mikami, Stephen R. Brooks, Yuka Kanno, Ronald E. Gress, et al.

    Aberrant differentiation of progenitor cells in the hematopoietic system is known to severely impact host immune responsiveness. Here we demonstrate that NOD1, a cytosolic innate sensor of bacterial peptidoglycan, also functions in murine hematopoietic cells as a major regulator of both the generation and differentiation of lymphoid progenitors as well as peripheral T lymphocyte homeostasis. We further show that NOD1 mediates these functions by facilitating STAT5 signaling downstream of hematopoietic cytokines. In steady-state, loss of NOD1 resulted in a modest but significant decrease in numbers of mature T, B and natural killer cells. During systemic protozoan infection this defect was markedly enhanced, leading to host mortality. Lack of functional NOD1 also impaired T cell-dependent anti-tumor immunity while preventing colitis. These findings reveal that, in addition to its classical role as a bacterial ligand receptor, NOD1 plays an important function in regulating adaptive immunity through interaction with a major host cytokine signaling pathway.


  • A central role for STAT5 in the transcriptional programing of T helper cell metabolism

    by Alejandro V. Villarino, Arian Dj Laurence, Fred P. Davis, Luis Nivelo, Stephen R. Brooks, Hong-Wei Sun, Kan Jiang, Behdad Afzali, Daniela Frasca, Lothar Hennighausen, et al.

    Activated lymphocytes adapt their metabolism to meet the energetic and biosynthetic demands imposed by rapid growth and proliferation. Common gamma chain (cγ) family cytokines are central to these processes, but the role of downstream signal transducer and activator of transcription 5 (STAT5) signaling, which is engaged by all cγ members, is poorly understood. Using genome-, transcriptome-, and metabolome-wide analyses, we demonstrate that STAT5 is a master regulator of energy and amino acid metabolism in CD4 + T helper cells. Mechanistically, STAT5 localizes to an array of enhancers and promoters for genes encoding essential enzymes and transporters, where it facilitates p300 recruitment and epigenetic remodeling. We also find that STAT5 licenses the activity of two other key metabolic regulators, the mTOR signaling pathway and the MYC transcription factor. Building on the latter, we present evidence for transcriptome-wide cooperation between STAT5 and MYC in both normal and transformed T cells. Together, our data provide a molecular framework for transcriptional programing of T cell metabolism downstream of cγ cytokines and highlight the JAK-STAT pathway in mediating cellular growth and proliferation.


  • MicroRNA-221 and -222 modulate intestinal inflammatory Th17 cell response as negative feedback regulators downstream of interleukin-23

    by Yohei Mikami, Rachael L. Philips, Giuseppe Sciumè, Franziska Petermann, Françoise Meylan, Hiroyuki Nagashima, Chen Yao, Fred P. Davis, Stephen R. Brooks, Hong-Wei Sun, et al.


  • Neuropeptide CGRP Limits Group 2 Innate Lymphoid Cell Responses and Constrains Type 2 Inflammation

    by Hiroyuki Nagashima, Tanel Mahlakõiv, Han-Yu Shih, Fred P. Davis, Francoise Meylan, Yuefeng Huang, Oliver J. Harrison, Chen Yao, Yohei Mikami, Joseph F. Urban, et al.


  • The Magnitude of IFN-γ Responses Is Fine-Tuned by DNA Architecture and the Non-coding Transcript of Ifng-as1

    by Franziska Petermann, Aleksandra Pękowska, Catrina A. Johnson, Dragana Jankovic, Han-Yu Shih, Kan Jiang, William H. Hudson, Stephen R. Brooks, Hong-Wei Sun, Alejandro V. Villarino, et al.